The trading price of Geron Corp (NASDAQ:GERN) floating higher at last check on current market day and closing at $2.92, 1.21% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $2.895 and $2.97. In examining the 52-week price action we see that the stock hit a 52-week high of $5.34 and a 52-week low of $1.64. Over the past month, the stock has lost -25.57% in value.
Geron Corp, whose market valuation is $1.77 billion at the time of this writing, is expected to release its quarterly earnings report in February. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.05 per share this quarter, however they have predicted annual earnings per share of -0.28 for current year and -0.07 for next year.
Analysts have forecast the company to bring in revenue of 59.01M for the current quarter, with the likely lows of 29.7M and highs of 164.4M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 90.06M.
On the technical side, indicators suggest GERN has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned GERN a recommendation rating is 5. Out of them, 1 rate it a Hold, while 4 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Geron Corp (GERN) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that GERN’s price is currently -10.93% off the SMA20 and -20.97% off the SMA50. The RSI metric on the 14-day chart is currently showing 28.18, and weekly volatility stands at 6.34%. When measured over the past 30 days, the indicator reaches 5.39%. Geron Corp (NASDAQ:GERN)’s beta value is currently sitting at 0.53, while the Average True Range indicator is currently displaying 0.17. With analysts defining $5.5-$8 as the low and high price targets, we arrive at a consensus price target of $7 for the trailing 12-month period. The current price is about -88.36% off the estimated low and -173.97% off the forecast high, based on this estimate. Investors will be thrilled if GERN’s share price rises to $7, which is the median consensus price. At that level, GERN’s share price would be -139.73% below current price.
To see how Geron Corp stock has been performing today in comparison to its peers in the industry, here are the numbers: GERN stock’s performance was 1.21% at last check in today’s session, and 52.34% in the past year.
An evaluation of the daily trading volume of Geron Corp (NASDAQ:GERN) indicates that the 3-month average is 10.38 million. However, this figure has increased over the past 10 days to an average of 12.5.
Currently, records show that 603.10 million of the company’s shares remain outstanding. The insiders hold 6.59% of outstanding shares, whereas institutions hold 78.47%. The stats also highlight that short interest as of 2024-12-31, stood at 65.07 million shares, resulting in a short ratio of 5.7 at that time. From this, we can conclude that short interest is 1082.00 of the company’s total outstanding shares. It is noteworthy that short shares in December were down slightly from the previous month’s figure, which was 66.35 million. However, since the stock’s price has seen -17.37% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
